DNA Genotek

Are you looking for a turnkey solution that streamlines your supply chain logistics along with customization options that reflect your brand and current workflow desired image? Our team of experts understands the pain points that test developers can benefit from outsourcing, so they can focus on core business activities and speed up time to market. We have produced unique customizations for research, commercial and direct-to-consumer (DTC) clients around the world. Read what The Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center has to say about our services and learn more here: https://lnkd.in/ejvcuCpE

DNA Genotek Inc. looks forward to welcoming you at ASHG at booth #223. Our team would like to understand your research goals and address how our collection devices for various sample types can meet your needs. Our range includes Oragene™ and ORAcollect™ devices for DNA or RNA from saliva, prepIT™ extraction reagents, OMNIgene™∙SALIVA DNA and RNA device for human and microbial total nucleic acids from saliva, OMNIgene™∙GUT device for microbial DNA from stool, and Colli-Pee™ urine collection device. We are also excited to present a Poster addressing how ‘Saliva DNA can support long-read sequencing technologies to improve resolution of complex genomic regions’. Poster Board Number: 1165T on Thursday, November 7, 2024, 2:30-4:30 p.m.

We’re excited to kick off the Global Engage #Microbiome & #Probiotic R&D & Business Collaboration Forum today in San Diego, California! Join us today and tomorrow to see how our sample collection devices can transform your microbiome research. Stop by booth 14 to meet our team and discover the latest advancements. We can’t wait to connect with you! #DNAGenoktek #MicrobiomeForum

The Global Engage #Microbiome & #Probiotic R&D & Business Collaboration Forum is just around the corner! Join us in San Diego, California, on October 17-18 to explore our sample collection devices for microbiome research. This is your chance to meet our team and learn more about how we can support you. We look forward to seeing you there! #DNAGenoktek #MicrobiomeForum

DETECT-2 (Direct to Patient Testing At Cancer Diagnosis for Precision Prevention-2) is a study evaluating if people with cancer who need genetic testing are willing to perform the test at home instead of the hospital. The study will assess how many patients accept testing, and the impact of genetic testing on a person’s mental well-being, satisfaction, and quality of life. It will also test if genetic testing at home is cost-effective. DETECT-2 is studying Direct to Patient testing where patients are offered testing at home using a saliva kit. DNA Genotek Inc. is pleased to support this research into a new scalable genetic testing pathway for people with bowel (colorectal), womb (endometrial), and ovarian cancer, through our Oragene™•Dx saliva collection devices easily used at people’s homes. Learn more about the Oragene™•Dx saliva collection device here: https://lnkd.in/eDQJSb9D Ranjit Manchanda Wolfson Institute of Population Health (QMUL)

Did you miss our webinar on optimizing results from saliva-derived DNA? Mike Tayeb discusses best practices for working with saliva-derived DNA samples, from pre-analytical processing to result optimization, and Dr. Masita Arip discusses sample type insights from Stem Cell Transplantation: Maximizing HLA-Match Accuracy Using Saliva-Derived DNA. View the webinar and download the protocol on streamlined processing for whole exome sequencing using the prepIT™•Q2A reagent with the ORAcollect™•Dx or Oragene™•Dx saliva collection devices. https://lnkd.in/eS8c3-Tq

We are just one week away from International Society of Microbiota’s Annual Conference - Targeting Microbiota 2024 in Malta! Join our team on October 14-15 to dive into the vast opportunities in microbiomics, metabolomics, and transcriptomics. Don’t miss out on the chance to connect with our team. See you there! #DNAGenotek #Microbiota2024 #Research #Microbiomics #Metabolomics #Transcriptomics

The countdown is on to the Global Engage #Microbiome & #Probiotic R&D & Business Collaboration Forum in San Diego, California, on October 17-18! We’re excited to be sponsoring this event, focused on exploring the challenges and opportunities in translating research toward commercialization. Join us and explore how our sample collection devices can enhance your microbiome research. See you there! #DNAGenoktek #MicrobiomeForum

Save the date! Join us at the International Society of Microbiota’s Annual Conference - Targeting Microbiota 2024, October 14-15, in beautiful Malta. We are pleased to be sponsoring this annual event and our team will be there to help you explore the vast opportunities to increase participant access and supporting research in microbiomics, metabolomics and transcriptomics. See you soon! #DNAGenotek #Microbiota2024 #Research #Microbiome #Metabolomics #Transcriptomics

Under the Final FDA LDT rule, LDTs may incur significant new costs to comply with specific quality system requirements, such as design control, and will require the regulatory burden of LDT submission to the FDA for approval as an IVD. Sample collection devices are a critical preanalytical input into your clinical laboratory test system. As a leading provider, DNA Genotek Inc. is here to answer your questions and to help navigate the complexity of the new rule. Read this Q&A with Trace Custer SVP Quality and Regulatory, learn how our expertise and data can support you in qualifying FDA-cleared sample collection devices in your laboratory workflow and support your FDA compliance. https://lnkd.in/g_2QW6Ax